← Return to Aromatase Inhibitors: Did you decide to go on them or not?
DiscussionAromatase Inhibitors: Did you decide to go on them or not?
Breast Cancer | Last Active: May 12, 2023 | Replies (1190)Comment receiving replies
Replies to "Exactly! This is totally wrong.. Breastcancer.org is still saying, which is completely flat out incorrect, that..."
I am trying to understand. Oncotype does two things: assesses risk of distant recurrence, and benefit of chemo. So if risk is low wouldn't that help a patient decide not to have radiation>
I think it is different for mastectomy patients, many of whom do not have radiation. This was my biggest decision. I was told that one in five radiologists would suggest radiation for me, and my tumor board said no.. My low Oncotype (and assumed low recurrence risk at that time) definitely affected my decision not to have radiation.